Tower Research Capital (TRC)’s IGC Pharma IGC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.64K | Sell |
11,899
-1,454
| -11% | -$445 | ﹤0.01% | 4459 |
|
2025
Q1 | $3.81K | Buy |
13,353
+2,310
| +21% | +$658 | ﹤0.01% | 4346 |
|
2024
Q4 | $3.71K | Buy |
11,043
+547
| +5% | +$184 | ﹤0.01% | 4608 |
|
2024
Q3 | $4.48K | Buy |
10,496
+2,478
| +31% | +$1.06K | ﹤0.01% | 4532 |
|
2024
Q2 | $3.48K | Sell |
8,018
-5,636
| -41% | -$2.45K | ﹤0.01% | 4885 |
|
2024
Q1 | $5.46K | Sell |
13,654
-9,663
| -41% | -$3.87K | ﹤0.01% | 4539 |
|
2023
Q4 | $6.53K | Buy |
23,317
+1,982
| +9% | +$555 | ﹤0.01% | 4728 |
|
2023
Q3 | $7.66K | Buy |
21,335
+654
| +3% | +$235 | ﹤0.01% | 4446 |
|
2023
Q2 | $6.45K | Sell |
20,681
-114
| -0.5% | -$36 | ﹤0.01% | 4679 |
|
2023
Q1 | $7K | Buy |
20,795
+10,703
| +106% | +$3.6K | ﹤0.01% | 4741 |
|
2022
Q4 | $3K | Buy |
+10,092
| New | +$3K | ﹤0.01% | 5195 |
|
2022
Q2 | – | Sell |
-1,364
| Closed | -$1K | – | 6270 |
|
2022
Q1 | $1K | Buy |
1,364
+968
| +244% | +$710 | ﹤0.01% | 5804 |
|
2021
Q4 | $0 | Buy |
+396
| New | – | ﹤0.01% | 6330 |
|
2021
Q1 | – | Sell |
-28,742
| Closed | -$45K | – | 5535 |
|
2020
Q4 | $45K | Buy |
28,742
+23,987
| +504% | +$37.6K | ﹤0.01% | 3213 |
|
2020
Q3 | $5K | Buy |
+4,755
| New | +$5K | ﹤0.01% | 4357 |
|
2015
Q3 | – | Sell |
-43
| Closed | – | – | 4367 |
|
2015
Q2 | $0 | Hold |
43
| – | – | ﹤0.01% | 4683 |
|
2015
Q1 | $0 | Sell |
43
-91
| -68% | – | ﹤0.01% | 4652 |
|
2014
Q4 | $0 | Hold |
134
| – | – | ﹤0.01% | 4320 |
|
2014
Q3 | $0 | Hold |
134
| – | – | ﹤0.01% | 4631 |
|
2014
Q2 | $0 | Buy |
134
+27
| +25% | – | ﹤0.01% | 4326 |
|
2014
Q1 | $0 | Buy |
107
+93
| +664% | – | ﹤0.01% | 4676 |
|
2013
Q4 | $0 | Buy |
14
+7
| +100% | – | ﹤0.01% | 4683 |
|
2013
Q3 | $0 | Sell |
7
-218
| -97% | – | ﹤0.01% | 4671 |
|
2013
Q2 | $0 | Buy |
+225
| New | – | ﹤0.01% | 3944 |
|